Michael Manning

Long-Term Prophylactic Treatment with Oral Deucrictibant Improved Health-Related Quality of Life in Participants with Hereditary Angioedema: Final Results of the Phase 2 CHAPTER-1 Open-Label Extension Study

Michael Manning, John Anderson, Francesco Arcoleo, Mauro Cancian et autres

Ouganda, bg, us, it, ca, ie, gb, at, de, pl, br (code pays fourni par la source)

OUTCOMES OF DEUCRICTIBANT-TREATED UPPER AIRWAY AND LARYNGEAL HEREDITARY ANGIOEDEMA ATTACKS: RAPIDE-2 PART A RESULTS

J. Anderson, Emel Aygören‐Pürsün, Henriette Farkas, Joshua Jacobs et autres

PHASE 2 OPEN-LABEL EXTENSION STUDY OF DONIDALORSEN IN PATIENTS WITH HEREDITARY ANGIOEDEMA: A 4-YEAR ANALYSIS

Michael Manning, Laura Bordone, Ken B. Newman, Yiwen Deng et autres

MAPPING PATIENT-REPORTED OUTCOME MEASURES ACROSS CLINICAL TRIALS IN HEREDITARY ANGIOEDEMA (HAE)

Michael Manning, N. Narsipur, J. Anderson, Andrew M. Smith et autres

us (code pays fourni par la source)

Quality of life and burden of disease in patients with hereditary angioedema and their caregivers

Donald S. Levy, Antoinette Cheung, Deirdre A. Rodeberg, Michael Manning

us, ca, gb, de (code pays fourni par la source)

Long-Term Safety and Effectiveness of Sebetralstat: Interim Analysis of KONFIDENT-S Open-label Extension

John Anderson, Laurence Bouillet, Teresa Caballero, Mauro Cancian et autres

hu, us, fr, es, it, vn, jp, mk, ca, gb, at, nz, de, au, Afrique du Sud, bg, pl, nl (code pays fourni par la source)

Donidalorsen Treatment of Hereditary Angioedema in Patients Previously on Long-Term Prophylaxis

Marc A. Riedl, Jonathan A. Bernstein, Joshua Jacobs, Timothy Craig et autres

us, vn, it, nl (code pays fourni par la source)

Sustained Effectiveness, Tolerability, and Safety of Long-Term Prophylaxis with Lanadelumab in Hereditary Angioedema: The Prospective, Phase 4, Noninterventional EMPOWER Real-World Study

Jonathan A. Bernstein, Stephen Betschel, Paula J. Busse, Aleena Banerji et autres

us, ca, pr, vn (code pays fourni par la source)

Long-term safety and efficacy of once-daily berotralstat in patients with hereditary angioedema

Henriette Farkas, Jonny Peter, Marcin Stobiecki, John Anderson et autres

hu, Afrique du Sud, pl, us, de, il, sk, gb, at (code pays fourni par la source)

Indirect treatment comparison of oral sebetralstat and intravenous recombinant human C1 esterase inhibitor for on-demand treatment of hereditary angioedema attacks

H. Henry Li, Emel Aygören‐Pürsün, Markus Magerl, Timothy Craig et autres

us, de, vn, gb (code pays fourni par la source)

Long-Term Safety and Efficacy of Oral Deucrictibant for Treatment of Hereditary Angioedema Attacks: Results of the RAPIDe-2 Extension Study

Michael Manning, John Anderson, Emel Aygören‐Pürsün, Laurence Bouillet et autres

us, de, fr, ca, hu, cz, es, il, it, bg, pl, ch (code pays fourni par la source)

Patient-Reported Impact of Berotralstat as Long-Term Prophylaxis on Hereditary Angioedema Attack Frequency and Attack Severity

Michael Manning, Lindsey Noble, Tamara Ray, Clare Murphy

us (code pays fourni par la source)